File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: The Capsid Assembly Modulator ALG-000184 dosed for 28 days was well tolerated and rapidly reduced viral markers in subjects with chronic hepatitis B, including HBsAg in a subset of HBeAg positive subjects with elevated baseline ALT

TitleThe Capsid Assembly Modulator ALG-000184 dosed for 28 days was well tolerated and rapidly reduced viral markers in subjects with chronic hepatitis B, including HBsAg in a subset of HBeAg positive subjects with elevated baseline ALT
Authors
Issue Date31-Mar-2023
PublisherSpringer
Persistent Identifierhttp://hdl.handle.net/10722/340240
ISSN
2021 Impact Factor: 9.029
2020 SCImago Journal Rankings: 1.304

 

DC FieldValueLanguage
dc.contributor.authorGane, E-
dc.contributor.authorYuen, MF-
dc.contributor.authorAgarwal, K-
dc.contributor.authorJuov, A-
dc.contributor.authorHou, J-
dc.contributor.authorNiu, J-
dc.contributor.authorMassetto, B-
dc.contributor.authorLe, K-
dc.contributor.authorLin, TI-
dc.contributor.authorMcClure, M-
dc.date.accessioned2024-03-11T10:42:43Z-
dc.date.available2024-03-11T10:42:43Z-
dc.date.issued2023-03-31-
dc.identifier.issn1936-0533-
dc.identifier.urihttp://hdl.handle.net/10722/340240-
dc.languageeng-
dc.publisherSpringer-
dc.relation.ispartofHepatology International-
dc.titleThe Capsid Assembly Modulator ALG-000184 dosed for 28 days was well tolerated and rapidly reduced viral markers in subjects with chronic hepatitis B, including HBsAg in a subset of HBeAg positive subjects with elevated baseline ALT-
dc.typeConference_Paper-
dc.identifier.volume17-
dc.identifier.issueS1-
dc.identifier.spageS82-
dc.identifier.epageS83-
dc.identifier.eissn1936-0541-
dc.identifier.issnl1936-0533-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats